Bacteriostatic antibiotics promote CRISPR-Cas adaptive immunity by enabling increased spacer acquisition. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.chom.2021.11.014

PubMed Identifier: 34932986

Publication URI: http://europepmc.org/abstract/MED/34932986

Type: Journal Article/Review

Volume: 30

Parent Publication: Cell host & microbe

Issue: 1

ISSN: 1931-3128